Top PDF MicroRNA expression and clinical outcome of small cell lung cancer.
MicroRNA expression and clinical outcome of small cell lung cancer.
... role of microRNAs in small-cell lung carcinoma (SCLC) is largely ...suppressor microRNA in many cancer ...a cancer type with frequent dysfunction of ...the ...
8
Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country.
... variation of efficacy of tumor cell vaccine raised a question of whether and to what extent is the T cell immunity provoked by systemic injection of tumor cell ...
7
Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression
... role of miR-486 in cancers has been extensively ...breast cancer (27), HCC (28), and gastric cancer ...in lung tumors compared with adjacent uninvolved lung tissues and ...
7
Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines.
... field of tumor lymphan- giogenesis ...VEGF-C, and VEGF-D have all been reported to promote tumor lymphangiogenesis ...use cell lines that have been genetically engineered to overex- press a lymphatic ...
15
Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
... using clinical cut-off determination, pretreatment albumin lost its significance on predicting outcome for NSCLC, and ANPG was also disqualified for independent prognostic factor in multivariate ...
14
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice
... development of new diagnostic, prognostic and predictive markers could significantly enhance its early detection ...Tissue Cancer (CASTLE) network are particularly ...plasma and serum samples ...
13
Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer.
... cancers and some normal reproductive tissues [16, ...physiologic and pathologic conditions, includ- ing the cytoskeletal structure [8], apoptotic pathways [11], epigenetic regulation of tumor ...
10
Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
... sections and deparaf- ...used and cell nuclei were counterstained with DAPI (Sigma Aldrich, ...presence of the respective target protein. A detailed list of anti- bodies and ...
15
Selectins mediate small cell lung cancer systemic metastasis.
... number of spontaneous lung metastases than those with lower number of adhesive events ...pattern of human SCLC cell lines in E- and P-selectin deficient pfp/rag2 mice in ...
11
MicroRNA-dependent regulation of transcription in non-small cell lung cancer.
... 37uC and inactivation at 85 uC for 5 min. The TaqMan Gene Expression Assay system (Applied Biosystems) was used for quantitating transcription levels of selected genes (CEACAM6, CGN, CLDN3, ABCC3, ...
13
The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.
... survival of cancer cells in breast, prostate, ovary, and brain tissue ...survival of NSCLC cell [29]. Recently, a clinical study of p-AKT expression in tissue from ...
6
Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.
... treatment of advanced NSCLC, a large proportion of patients display varying levels of resistance, indicating a remarkable individual variability in the therapeutic efficacy and ...in ...
11
Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.
... organisation of healthy cells, with a small popula- tion of Cancer Stem Cells (CSCs) driving a heterogeneous, hierarchical structure [1, ...abundance of CSCs is considered likely to be ...
23
Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.
... member of the PA family shown to accelerate cell migration in ...IHC expression level and patient ...limitation of the previous study was that the overexpression of each marker ...
15
Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.
... with lung cancer risk [5–7]. TERT en- codes the catalytic subunit of the telomerase ribonucleoprotein complex, which catalyzes the addition of telomeric repeats at the ends of ...
13
An Overview: Treatment of Lung Cancer on Researcher Point of View
... ung cancer leads to death including both man & woman ...diagnosis of lung cancer in patient. The risk of most redundant outcome of this disease (death) can be ...
7
Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancer.
... human lung and lung cancer tissues or A549 cells using Trizol reagent (Invitrogen, ...USA) and random primers (Promega, ...intron and the sequences were given in the Table ...ml, ...
11
Inglês Jornal Brasileiro de Pneumologia complete v42n5 EN
... role of tuberculosis as a public health care priority and the availability of diagnostic tools to evaluate functional status (spirometry, plethysmography, and DLCO determination), arterial ...
102
J. bras. pneumol. vol.36 número5 en v36n5a14
... most of the data related to patients with specific details regarding nodal status came from ...the small number of patients in each ...edition of the TNM staging system for lung ...N1 ...
4
TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma.
... Lung cancer is the most common cause of cancer death in western ...recurrence and metastasis are frequent events despite the establishment of multiple lines of therapy ...
11